Patients at high risk for having a nonfatal MI or of dying from a coronary event based on low-density lipoprotein levels and other factors used to generate a risk score have a goal LDL level of ______.
They should consider drug therapy for LDL levels of ____.
The high risk category includes patients who have CAD, peripheral vascular disease, or ACS
They should consider drug therapy for LDL levels of >100. 70-100 is reasonable to treat to < 70.